Abstract: Background: coronavirus disease is characterized by hypercoagulation and requires treatment with anticoagulants. At the background of anticoagulant therapy, life-threatening soft tissue bleeding may occur. Aim: was to evaluate the efficacy of transcatheter arterial embolization in patients with severe COVID-19 complicated by soft tissue bleeding. Materials and methods: within the period from January 30, 2021 to February 18, 2022, transcatheter arterial embolization of soft tissue bleeding was performed in 25 patients with COVID-19-associated pneumonia. Results: transcatheter arterial embolization was performed in 19 of 25 patients (76%). Postoperative mortality was 42%, and overall mortality was 40%. Fifteen patients (60%) were discharged in satisfactory condition. Conclusions: severe soft tissue bleeding may occur in patients with coronavirus disease while treated with anticoagulants. The method of choice for treatment of these hemorrhages is transcatheter arterial embolization.
Abstract: The article presents the experience of stenting the internal carotid arteries (ICA) in 45 patients. The patients' age ranged from 49 to 78 years, on average 64.8 years. The degree of ICA stenosis ranged from 60% to 95%, on average 72.7 ± 7.2%. 28 (62.2%) patients had a history of acute cerebrovascular accident, 17 (37.7%) patients had cerebral symptoms of circulatory disorders. After 48 endovascular procedures, neurological complications developed in 3 (6.2%) cases: transient ischemic attack - in 2 (4.1%) patients, minor stroke - in one (2%) patient. Hospital mortality was 2.2%. In the remote period, 13 (28.8%) patients were examined. There were no myocardial infarctions and strokes.
